CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF - CHALLENGER LIMITED

FNArena Sector : Wealth Management & Investments
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.01

10 Jan
2025

-0.010

OPEN

$6.05

-0.17%

HIGH

$6.08

934,581

LOW

$5.99

TARGET
$7.614

-0.14 change from previous day

 26.7% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . AVC . BVS . CVW . DJW . ENN . GDC . GDG . GQG . HMC . HUB . IFL . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 19.0 59.2 xxx
DPS (cps) xxx 26.5 27.9 xxx
EPS Growth xxx - 55.0% 100.0% xxx
DPS Growth xxx 10.4% 5.4% xxx
PE Ratio xxx N/A 10.1 xxx
Dividend Yield xxx N/A 4.7% xxx
Div Pay Ratio(%) xxx 139.6% 47.2% xxx

Dividend yield today if purchased 3 years ago: 4.05%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 4.42

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - ex-div 13.50c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx19.0
DPS All xxxxxxxxxxxxxxx26.5
Sales/Revenue xxxxxxxxxxxxxxx2,907.7 M
Book Value Per Share xxxxxxxxxxxxxxx568.0
Net Operating Cash Flow xxxxxxxxxxxxxxx843.7 M
Net Profit Margin xxxxxxxxxxxxxxx4.63 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx3.35 %
Return on Invested Capital xxxxxxxxxxxxxxx2.45 %
Return on Assets xxxxxxxxxxxxxxx0.42 %
Return on Equity xxxxxxxxxxxxxxx3.35 %
Return on Total Capital xxxxxxxxxxxxxxx11.14 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx692.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx5,593 M
Long Term Debt xxxxxxxxxxxxxxx1,532 M
Total Debt xxxxxxxxxxxxxxx7,126 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx573 M
Price To Book Value xxxxxxxxxxxxxxx1.23

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.07 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx828 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx31,000 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xx-xxxxxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

17/10/2024

1

Add

$8.20

36.44%

Morgans considers Challenger reported a "soft" 1Q25 earnings report with total life sales declining -14% on the previous year.

Retail fixed term annuity sales fell -22% and lifetime sales rose 26 while Japanese sales lifted 75% and Index Plus sales advanced 55%, all compared to the previous corresponding period.

The broker lowers EPS estimates by -1% in FY25 and -7% in FY26.

Target price declines to $8.20 from $8.60. No change to Add rating.

FORECAST
Morgans forecasts a full year FY25 dividend of 25.90 cents and EPS of 59.00 cents.
Morgans forecasts a full year FY26 dividend of 27.60 cents and EPS of 61.40 cents.

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

21/10/2024

1

Buy

$7.82

30.12%

As part of Challenger's 1Q update, management reaffirmed FY25 profit guidance but a weaker capital position reduces the company's flexibility to fund earnings growth into FY26, explains Goldman Sachs.

Annuity book growth declined by -1.2% in Q1 and Life annuity sales were down -37% versus the previous corresponding period, impacted by the Aware Super lifetime sale in Q1, note the analysts.

Buy rating and the target falls to $7.82 from $8.00.

FORECAST
Goldman Sachs forecasts a full year FY25 dividend of 27.00 cents and EPS of 42.00 cents.
Goldman Sachs forecasts a full year FY26 dividend of 28.00 cents and EPS of 48.00 cents.
Access Extra Coverage Research History >

CGF STOCK CHART

FNArena News on CGF

1
Next Week At A Glance – 9-13 Dec 2024

Dec 06 2024 - Weekly Reports
2
Rudi’s View: A Cautious Preview Into 2025

Dec 04 2024 - Rudi's View
3
Rudi’s View: Australia’s Most Highly Recommended Stocks

Oct 23 2024 - Rudi's View
4
Australian Broker Call *Extra* Edition – Oct 22, 2024

Oct 22 2024 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Oct 21, 2024

Oct 21 2024 - Daily Market Reports

Latest Wealth Management & Investments News

1
Monthly Listed Investment Trust Report – Dec 2024

Dec 18 2024 - Australia
2
Weekly Update On LICs & LITs – 17-Dec-2024

Dec 17 2024 - Weekly Reports
3
GQG Partners Shrugs Off Adani

Dec 13 2024 - Small Caps
4
Generation Development, The Next Hub24?

Dec 12 2024 - Small Caps
5
Weekly Update On LICs & LITs – 10-Dec-2024

Dec 10 2024 - Weekly Reports
6
Weekly Update On LICs & LITs – 03-Dec-2024

Dec 03 2024 - Weekly Reports
7
Weekly Update On LICs & LITs – 26-Nov-2024

Nov 26 2024 - Weekly Reports
8
Weekly Update On LICs & LITs – 19-Nov-2024

Nov 19 2024 - Weekly Reports
9
Weekly Update On LICs & LITs – 12-Nov-2024

Nov 12 2024 - Weekly Reports
10
Australian Listed Investment Company Report – Nov 2024

Nov 11 2024 - Australia